Japan approves Roxadustat for non-dialysis anemia in chronic kidney disease
Astellas Pharma and FibroGen have received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for the…
Protalix BioTherapeutics receives FDA extension for pegunigalsidase alfa review: What this means for Fabry disease treatment
Protalix BioTherapeutics, a leader in the development of innovative therapies for rare diseases, has announced a significant update…
Haoma Medica completes first-in-human trial of NaQuinate, a promising osteoporosis treatment
Haoma Medica, a UK-based biotechnology company, has successfully wrapped up the first-in-human clinical trial of NaQuinate, a novel…
Cantargia partners with BioInvent International for CAN10 manufacturing contract
Sweden-based biopharmaceutical company Cantargia has entered a significant partnership with BioInvent International to advance the manufacturing of CAN10,…
Antengene receives approval for ATG-016 clinical trial in myelodysplastic syndrome
Antengene, a leading Chinese biopharmaceutical company, has announced a significant milestone with the approval of its Phase 1/2…
RedHill Biopharma expands U.S. partnerships for opaganib manufacturing amid COVID-19 fight
Israeli biopharma company RedHill Biopharma has significantly advanced its efforts to combat COVID-19 by forging strategic partnerships with…
PostEra collaborates with NeuroLucent to accelerate Alzheimer’s drug discovery
In a strategic move aimed at fast-tracking the development of new treatments for Alzheimer’s disease, PostEra, a UK-based…
PostEra partners with NeuroLucent to accelerate Alzheimer’s drug development using AI and machine learning
In a significant move within the biotech industry, PostEra, a UK-based biotechnology company, has entered into a strategic…
CoSara Diagnostics gains CDSCO approval for Saragene COVID-19 2-gene multiplex RT-PCR test
CoSara Diagnostics, a prominent player in the field of molecular diagnostics, has achieved a significant milestone with the…
Merck seeks FDA and EMA approvals for V114 pneumococcal conjugate vaccine candidate
Merck & Co., a global leader in pharmaceutical development, has submitted applications to the US Food and Drug…